Loading...
XKRX
097950
Market cap1.87bUSD
Jul 09, Last price  
191,200.00KRW
1D
-3.53%
1Q
-19.83%
Jan 2017
-46.52%
IPO
-39.11%
Name

CJ CheilJedang Corp

Chart & Performance

D1W1MN
XKRX:097950 chart
P/E
—
P/S
0.10
EPS
—
Div Yield, %
3.92%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
2.43%
Revenues
27.34t
-6.87%
1,290,303,984,0004,540,866,943,0004,994,476,776,0005,669,203,273,0006,538,208,074,0009,877,532,183,00010,847,718,244,00011,701,797,228,00012,924,472,295,00014,563,257,246,00016,477,174,023,00018,670,059,989,00022,352,462,296,00024,245,725,654,00026,289,227,767,00030,079,513,121,00029,023,472,909,00029,359,081,823,00027,342,589,100,000
Net income
-571.46b
L
16,714,022,00020,039,045,000274,279,279,000683,270,205,000301,489,470,000254,879,243,000116,659,513,00091,956,503,000189,259,968,000275,909,511,000370,154,579,000875,157,276,000152,546,157,000685,581,662,000612,890,498,000595,929,977,000385,927,260,000148,181,177,000-571,455,620,000
CFO
1.99t
-11.70%
239,916,527,000-49,867,817,000667,907,120,00064,117,601,000-288,381,082,000805,051,777,000590,904,368,000688,561,505,0001,154,573,133,000800,141,934,0001,180,837,049,000471,425,123,0002,143,095,681,0002,001,752,173,0001,686,409,257,0001,627,293,112,0002,444,759,803,0002,255,253,477,0001,991,469,848,000
Dividend
Nov 27, 20251500 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

CJ Cheiljedang Corporation is an enterprise involved in both the food and biotechnology sectors. The company's diverse food product range encompasses prepared meats, frozen meals, fresh produce, a variety of seasonings, sweeteners, flours, cooking oils, starches, along with specialty items such as seaweed, desserts, snacks, and health-functional foods. In its bio division, it manufactures amino acids and animal feed. Established in 1953, CJ Cheiljedang Corporation is based in Seoul, South Korea.
URL
https://www.cj.co.kr/
IPO date
Sep 28, 2007
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT